Furthermore, serine-threonine protein kinase (Akt), an upstream regulator of GSK3β, could facilitate GSK3β phosphorylation to inhibit GSK3β activity and thus has been implicated in modulating depression and other neuropsychopathies (Wang et al., 2021). This evidence concerns the gene GSK3B and major depressive disorder.